has established a comprehensive RNA manufacturing facility, and provides a wide range of open-access technology platforms and services including RNAi, gRNA, mRNA therapeutics, RNA biomarkers. These are all designed to enable efficient development of medicines for customers and support for contract researchprograms.The company's technology uses RNA made of nucleotide analogs targeting the key genes to produce therapeutic effect, synthetic gRNA based genome-editing and mRNA cancer vaccine to treat a wide range of diseases, including those that cannot be effectively treated with existing methods to develop and manufacture drugs.